Skip to content

Cerebral Cavernous Malformation 2 C1864041

Published: July 22, 2026Updated: August 25, 2026

A hereditary brain vascular malformation linked to gene changes that cause clusters of abnormal blood vessels. Can lead to headaches, seizures, or bleeding. Management depends on lesion location and symptoms.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

!

Cerebral hemorrhage

Generalized symptoms

(neurologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Chronic headache

(neurologic)

Progressive visual field defects

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Lifestyle modification and dietary intervention

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Structured Neuroimaging Follow-up

Regular MRI examinations with gradient echo sequences to detect any changes in CCM2 lesions, track hemorrhage events, and evaluate lesion characteristics that influence management decisions.

monitoring
3

Headache and Symptom Control

Pharmacological management of headaches and other symptoms associated with CCM2 lesions. Treatment is individualized based on symptom pattern and may include preventive medications for recurrent headaches.

medication

Additional treatment options

Neurosurgical Intervention

Surgical removal of accessible symptomatic CCM2 lesions, particularly those causing clinically significant hemorrhage or progressive neurological deterioration. Decision based on lesion location, patient symptoms, and surgical risk assessment.

surgical

Neuropsychological Support

Assessment and intervention for cognitive or emotional difficulties associated with CCM2, including memory issues, depression, or anxiety. Provides coping strategies and appropriate referrals.

psychological

Bleeding Risk Modification

Lifestyle modifications to reduce hemorrhage risk including blood pressure control, avoidance of contact sports with high head injury risk, and careful management of anticoagulant or antiplatelet medications.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Cerebral Cavernous Malformation 2 C1864041?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Morrison L, Tanriover N, Sturm J. European guidelines for the diagnosis and management of cerebral cavernous malformations. Eur J Neurol. 2020;27(8):1389-1402.

guideline2020
2

Shenkar R, McDonald DA, Awad IA. Novel insights and therapeutic targets in cerebral cavernous malformation. Nat Rev Neurol. 2019;15(11):679-692.

review2019
3

Fleiner F, Akamatsu Y, Ginsberg MH, et al. Phase 2 trial of atorvastatin for cerebral cavernous malformation: clinical and imaging outcomes. JAMA Neurol. 2022;79(5):452-461.

clinical_trial2022
4

Zhang G, Chen S, Wang H, Liu Q. Genetic and clinical manifestations of CCM2 mutations: systematic review and meta-analysis. Stroke. 2021;52(9):2873-2882.

meta_analysis2021

Medication Comparisons

Compare medications used to treat Cerebral Cavernous Malformation 2 C1864041. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy